Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inmune Bio (INMB) Non-Current Deferred Tax Liability (2021)

Inmune Bio (INMB) has disclosed Non-Current Deferred Tax Liability for 1 consecutive years, with $257000.0 as the latest value for Q4 2021.

  • Quarterly Non-Current Deferred Tax Liability changed N/A to $257000.0 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $257000.0 through Dec 2021, changed N/A year-over-year, with the annual reading at $257000.0 for FY2021, N/A changed from the prior year.
  • Non-Current Deferred Tax Liability hit $257000.0 in Q4 2021 for Inmune Bio.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $257000.0 in Q4 2021 to a low of $257000.0 in Q4 2021.